Categories 2022 Corporate Events Board of Directors to approve Q1 2022 revenues and key KPIs (unaudited) Post author By Antonio Buono Post date 22 April 2022 Board of Directors to approve Q1 2022 revenues and key KPIs (unaudited). ← Farmacosmo, First Quarter Results Revenues + 20% YoY at € 17.7 Million → Assemblea dei soci per l’approvazione del bilancio al 31 dicembre 2021
Farmacosmo InvestorsFarmacosmo Investors